Article | October 05, 2026
Article | October 01, 2026
You Don’t Know What You’ve Got ’til It’s Gone: Regulatory Strategy for a Strained FDA
Read More
Article | September 28, 2026
Could New Anti-Kickback Protections Support Clinical Trial Participation?
Read More
Article | September 22, 2026
Gardner Law Expands Privacy and AI Practice with Addition of Mercy Ulo
Read More
Article | September 17, 2026
FDA Seeks Input on Regulatory Framework for Generative AI-Enabled Medical Devices
Read More
Article | September 15, 2026
Food as Medicine, Digital Health, and Medical Devices: The Next Frontier in Healthcare Compliance
Read More
Article | September 08, 2026
Can You Say It in 30 Seconds? Short-Form Video and the Limits of Promotional Compliance
Read More
Article | August 20, 2026
FDA Proposes Mandatory GRAS Notification, but Stops Short of Premarket Approval
Read More
Article | August 11, 2026
OIG Reaffirms: Fair Market Value Alone Does Not Eliminate Anti-Kickback Statute Risk
Read More
